Changes of Plasma Fasting Carnitine Ester Profile in Patients with Ulcerative Colitis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2006 Jan 28

PMID 16440427

Citations 12

Authors

Judit Bene

Katalin Komlosi

Viktoria Havasi

Gabor Talian

Beata Gasztonyi

Krisztina Horvath

Gyula Mozsik

Bela Hunyady

Bela Melegh

Maria Figler

Affiliations

Soon will be listed here.

Abstract

Aim: To determine the plasma carnitine ester profile in adult patients with ulcerative culitis (UC) and compared with healthy control subjects.

Method: Using ESI triple quadrupole tandem mass spectrometry, the carnitine ester profile was measured in 44 patients with UC and 44 age- and sex-matched healthy controls.

Results: There was no significant difference in the fasting free carnitine level between the patients with UC and the healthy controls. The fasting propionyl- (0.331 +/- 0.019 vs 0.392 +/- 0.017 micromol/L), butyryl- (0.219 +/- 0.014 vs 0.265 +/- 0.012), and isovalerylcarnitine (0.111 +/- 0.008 vs 0.134 +/- 0.008) levels were decreased in the UC patients. By contrast, the level of octanoyl-(0.147 +/- 0.009 vs 0.114 +/- 0.008), decanoyl- (0.180 +/- 0.012 vs 0.137 +/- 0.008), myristoyl- (0.048 +/- 0.003 vs 0.039 +/- 0.003), palmitoyl- (0.128 +/- 0.006 vs 0.109 +/- 0.004), palmitoleyl- (0.042 +/- 0.003 vs 0.031 +/- 0.002) and oleylcarnitine (0.183 +/- 0.007 vs 0.163 +/- 0.007; P < 0.05 in all comparisons) were increased in the patients with UC.

Conclusion: Our data suggest selective involvement of the carnitine esters in UC patients, probably due to their altered metabolism.

Citing Articles

Integrative Lipid Pseudotargeted Metabolomics and Amino Acids Targeted Metabolomics Unravel the Therapeutic Mechanism of Rhizoma Paridis Saponins on Experimental Colitis of Damp-Heat Type.

Wu Q, Liu K, Hou R, Wu X, Ruan X, Wang M Drug Des Devel Ther. 2024; 18:5087-5108.

PMID: 39554759 PMC: 11568858. DOI: 10.2147/DDDT.S476494.

Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways.

Liu M, Guo S, Wang L Therap Adv Gastroenterol. 2024; 17:17562848241239580.

PMID: 38560428 PMC: 10981261. DOI: 10.1177/17562848241239580.

A Preliminary Metabolomic Study of Yorkshire Terrier Enteropathy.

Galler A, Klavins K, Burgener I Metabolites. 2022; 12(3).

PMID: 35323707 PMC: 8954012. DOI: 10.3390/metabo12030264.

Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease.

Lee E, Yoon Y, Yoon J, Lee S, Oh Y, Kwon S Biomol Ther (Seoul). 2021; 29(6):582-595.

PMID: 34565718 PMC: 8551739. DOI: 10.4062/biomolther.2021.125.

Carnitine Serum Levels in Frail Older Subjects.

Malaguarnera G, Catania V, Bonfiglio C, Bertino G, Vicari E, Malaguarnera M Nutrients. 2020; 12(12).

PMID: 33352627 PMC: 7766818. DOI: 10.3390/nu12123887.

References

Kinsella J, Lokesh B, Broughton S, Whelan J . Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition. 1990; 6(1):24-44; discussion 59-62. View

Stenson W, Cort D, Rodgers J, Burakoff R, Gramlich T, Beeken W . Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992; 116(8):609-14. DOI: 10.7326/0003-4819-116-8-609. View

Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E . Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut. 1992; 33(10):1365-9. PMC: 1379605. DOI: 10.1136/gut.33.10.1365. View

Siguel E, Lerman R . Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism. 1996; 45(1):12-23. DOI: 10.1016/s0026-0495(96)90194-8. View

Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, WIEBECKE B . n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci. 1996; 41(10):2087-94. DOI: 10.1007/BF02093614. View

Scheppach W, Muller J, Boxberger F, Dusel G, Richter F, Bartram H . Histological changes in the colonic mucosa following irrigation with short-chain fatty acids. Eur J Gastroenterol Hepatol. 1997; 9(2):163-8. DOI: 10.1097/00042737-199702000-00010. View

Bene J, Komlosi K, Gasztonyi B, Juhasz M, Tulassay Z, Melegh B . Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol. 2006; 11(42):6671-5. PMC: 4355763. DOI: 10.3748/wjg.v11.i42.6671. View

Gasbarrini G, Mingrone G, Giancaterini A, De Gaetano A, Scarfone A, Capristo E . Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Hepatogastroenterology. 2003; 50(53):1385-9. View

Costa C, de Almeida I, Jakobs C, Poll-The B, Duran M . Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res. 1999; 46(4):440-4. DOI: 10.1203/00006450-199910000-00013. View

10.

Nelson R, ADSON M, PALMER W, Soule E . Pantothenic acid, coenzyme A, and human chronic ulcerative and granulomatous colitis. Am J Clin Nutr. 1976; 29(12):1333-8. DOI: 10.1093/ajcn/29.12.1333. View

11.

Roediger W . The colonic epithelium in ulcerative colitis: an energy-deficiency disease?. Lancet. 1980; 2(8197):712-5. DOI: 10.1016/s0140-6736(80)91934-0. View

12.

Roediger W, Heyworth M, Willoughby P, Piris J, Moore A, TRUELOVE S . Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol. 1982; 35(3):323-6. PMC: 497539. DOI: 10.1136/jcp.35.3.323. View

13.

Melegh B, Kerner J, Bieber L . Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol. 1987; 36(20):3405-9. DOI: 10.1016/0006-2952(87)90318-2. View

14.

Sandor A, Kispal G, Melegh B, Alkonyi I . Ester composition of carnitine in the perfusate of liver and in the plasma of donor rats. Eur J Biochem. 1987; 170(1-2):443-5. DOI: 10.1111/j.1432-1033.1987.tb13719.x. View

15.

Bieber L . Carnitine. Annu Rev Biochem. 1988; 57:261-83. DOI: 10.1146/annurev.bi.57.070188.001401. View

16.

Harig J, SOERGEL K, Komorowski R, Wood C . Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989; 320(1):23-8. DOI: 10.1056/NEJM198901053200105. View

17.

Lorenz R, Weber P, Szimnau P, Heldwein W, Strasser T, Loeschke K . Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl. 1989; 731:225-32. DOI: 10.1111/j.1365-2796.1989.tb01461.x. View

18.

Salomon P, Kornbluth A, Janowitz H . Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. J Clin Gastroenterol. 1990; 12(2):157-61. DOI: 10.1097/00004836-199004000-00009. View

19.

Scheppach W, Sommer H, Kirchner T, Paganelli G, Bartram P, Christl S . Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992; 103(1):51-6. DOI: 10.1016/0016-5085(92)91094-k. View